A prognostic model for oral squamous cell carcinoma patients with type 2 diabetes mellitus

被引:1
作者
Hu, Xin [1 ,2 ,3 ]
Xiong, Haofeng [1 ,2 ,3 ]
Huang, Shiying [1 ,2 ,3 ]
Zeng, Liujun [1 ,2 ,3 ]
Su, Tong [1 ,2 ,3 ]
机构
[1] Cent South Univ, Xiangya Hosp, Ctr Stomatol, Dept Oral & Maxillofacial Surg, Changsha, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Res Ctr Oral & Maxillofacial Tumor, Changsha, Peoples R China
[3] Cent South Univ, Inst Oral Precancerous Les, Changsha, Peoples R China
关键词
Nomograms; Oral squamous cell carcinoma; Type 2 diabetes mellitus; CANCER-RISK; METFORMIN; HYPERGLYCEMIA;
D O I
10.1016/j.archoralbio.2023.105735
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objective: To build a prognostic model for oral squamous cell carcinoma patients with type 2 diabetes mellitus. Design: Oral squamous cell carcinoma patients with type 2 diabetes mellitus in Xiangya Hospital were studied. Patients during January 2011 to January 2015 were included in training set (n = 146), and those during January 2017 to December 2020 were included in test set (n = 81). Univariate and multivariate Cox regressions were used to screen independent prognostic variables. Nomogram was used to show the model. C-index, internal bootstrap resampling and external validation were used to evaluate the model. Results: Six independent prognostic factors (T stage, N stage, pathological grade, metformin use, sulfonylureas use, and fasting blood glucose) were screened from training set. Based on the six variables, nomogram was constructed to predict the prognosis of oral squamous cell carcinoma patients with type 2 diabetes mellitus. Cindex value was 0.728, and result of internal bootstrap resampling showed better prediction efficiency for oneyear survival. All patients were divided into two groups according to total points calculated based on the model. Group with low total points experienced better survival than that with high total points both in training set and test set. Conclusions: The model provides a relatively accurate method to predict the prognosis of oral squamous cell carcinoma patients with type 2 diabetes mellitus.
引用
收藏
页数:9
相关论文
共 28 条
  • [1] Staging and grading of oral squamous cell carcinoma: An update
    Almangush, Alhadi
    Makitie, Antti A.
    Triantafyllou, Asterios
    de Bree, Remco
    Strojan, Primoz
    Rinaldo, Alessandra
    Hernandez-Prera, Juan C.
    Suarez, Carlos
    Kowalski, Luiz P.
    Ferlito, Alfio
    Leivo, Ilmo
    [J]. ORAL ONCOLOGY, 2020, 107
  • [2] Increased cancer-related mortality for patients with type 2 diabetes who use sulforrylureas or insulin
    Bowker, SL
    Majumdar, SR
    Veugelers, P
    Johnson, JA
    [J]. DIABETES CARE, 2006, 29 (02) : 254 - 258
  • [3] [Anonymous], 2020, CA Cancer J Clin, V70, P313, DOI [10.3322/caac.21492, 10.3322/caac.21609]
  • [4] Hyperglycemia, tumorigenesis, and chronic inflammation
    Chang, Shu-Chun
    Yang, Wei-Chung Vivian
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 108 : 146 - 153
  • [5] Metformin disrupts malignant behavior of oral squamous cell carcinoma via a novel signaling involving Late SV40 factor/Aurora-A
    Chen, Chang-Han
    Tsai, Hsin-Ting
    Chuang, Hui-Ching
    Shiu, Li-Yen
    Su, Li-Jen
    Chiu, Tai-Jan
    Luo, Sheng-Dean
    Fang, Fu-Min
    Huang, Chao-Cheng
    Chien, Chih-Yen
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [6] Sulfonylurea receptor 1-expressing cancer cells induce cancer-associated fibroblasts to promote non-small cell lung cancer progression
    Chen, Hongling
    Zhao, Li
    Meng, Yuting
    Qian, Xixi
    Fan, Ya
    Zhang, Quanli
    Wang, Chao
    Lin, Fan
    Chen, Baoan
    Xu, Lin
    Huang, Wenbin
    Chen, Jing
    Wang, Xuerong
    [J]. CANCER LETTERS, 2022, 536
  • [7] Type 2 diabetes mellitus promotes the proliferation, metastasis, and suppresses the apoptosis in oral squamous cell carcinoma
    Hu, Xin
    Wu, Jin
    Xiong, Haofeng
    Zeng, Liujun
    Wang, Zijia
    Wang, Can
    Huang, Danni
    Zhang, Tianyi
    Peng, Ying
    Chen, Weijun
    Xia, Kun
    Su, Tong
    [J]. JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2022, 51 (05) : 483 - 492
  • [8] Metformin reduces the increased risk of oral squamous cell carcinoma recurrence in patients with type 2 diabetes mellitus: A cohort study with propensity score analyses
    Hu, Xin
    Xiong, Haofeng
    Chen, Wenxin
    Huang, Long
    Mao, Ting
    Yang, Liudi
    Wang, Can
    Huang, Danni
    Wang, Zijia
    Yu, Jianjun
    Shu, Yan
    Xia, Kun
    Su, Tong
    [J]. SURGICAL ONCOLOGY-OXFORD, 2020, 35 : 453 - 459
  • [9] Huang Dan-Ni, 2021, Shanghai Kou Qiang Yi Xue, V30, P61
  • [10] Blood glucose concentration and risk of pancreatic cancer: systematic review and dose-response meta-analysis
    Liao, Wei-Chih
    Tu, Yu-Kang
    Wu, Ming-Shiang
    Lin, Jaw-Town
    Wang, Hsiu-Po
    Chien, Kuo-Liong
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2015, 349